Home Live CME Conferences

 

CONTACT INFORMATION

 

ACKNOWLEDGEMENTS

R.J. Fasenmyer Center for Clinical Immunology

Rheumatology Highlights Report Live
& Advances in B Cell Biology: RA, SLE, and Vasculitis

 

This unique program is being offered in two locations:

OCTOBER 22-23, 2010 Westin Times Square New York, New York

Description

Internationally recognized rheumatology authorities provide their unique medical perspectives on cutting-edge data presented at EULAR 2010, extracting and distilling the most pertinent information from the thousands of abstracts and presentations. These experts will discuss the changing landscape of rheumatology and its practical implications on clinical practice. Special emphasis will focus on identifying the most clinically germane advances in B-cell therapies for RA, SLE, and vasculitis.

Overall, these programs will be an excellent opportunity for health care practitioners to experience the best and most important aspects of EULAR 2010 without leaving the United States.

Back to Top

 

Target Audience

This symposium is directed to rheumatologists, immunologists, rheumatology and immunology fellows, clinical researchers, and rheumatology and immunology allied health professionals, including nurse practitioners and physician assistants.

Back to Top

 

Objectives

Rheumatology Highlights Report Live

• Describe advances in rheumatology-related therapeutics from recent national and international meetings;
• Critically appraise data on risks and benefits from new and emerging therapies;
• Discuss advances in key diseases including RA, spondyloarthopathies, psoriatic arthritis, SLE, vasculitis, gout, and metabolic bone disease;
• Review and discuss recent consensus statements on disease management.

Advances in B Cell Biology: RA, SLE, and Vasculitis

• Summarize research on advances in B-cell biology including the expanded role of B cells and their products in the integrated immune response;
• Describe the role of cytokine messengers, such as BLyS (BAFF) and APRIL, and their receptors in B-cell biology;
• Describe new strategies to interdict the role of B cells based on targeting cell-associated molecules such as CD20, CD22, CD19, and soluble factors such as BLyS, lymphotoxin beta, and others;
• Critically appraise new data on the efficacy and safety of currently approved B-cell targeting agents and describe emerging data on new B-cell targeting strategies in RA;
• Discuss results from clinical trials in patients with SLE and critically appraise data from recent clinical trials targeting B cells and their survival and maturation factors;
• Review the evolution and rationale for biologic therapies for systemic vasculitis and critically appraise data from recent international studies on B-cell directed therapies;
• Recognize and diagnose the key complications of biologic B-cell targeting therapies, including viral infections such as progressive multifocal leukoencephalopathy (PML).

Back to Top

 

Director
 

Leonard Calabrese, DO * Professor of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University R. J. Fasenmyer Chair of Clinical Immunology Vice Chairman, Department of Rheumatic and Immunologic Diseases Orthopaedic and Rheumatologic Institute Cleveland Clinic Cleveland, OH

Back to Top

 

Faculty
 

N. Lawrence Edwards, MD, FACP, FACR Professor of Medicine Division of Rheumatology and Clinical Immunology Vice Chairman and Program Director Department of Medicine University of Florida Gainesville, FL Allan Gibofsky, MD Professor of Medicine and Public Health Weill Cornell Medical College New York, NY Elaine Husni, MD, MPH Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Director, Clinical Outcomes Research Director, Arthritis and Musculoskeletal Treatment Center Department of Rheumatic and Immunologic Diseases Orthopaedic and Rheumatologic Institute Cleveland Clinic Cleveland, OH Jonathan Kay, MD * Director of Clinical Research Rheumatology Division Professor of Medicine University of Massachusetts Medical School Worcester, MA

Brian Mandell, MD, PhD Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Department of Rheumatic and Immunologic Diseases Orthopaedic and Rheumatologic Institute Cleveland Clinic Cleveland, OH William Rigby, MD * Vice-Chair, Department of Medicine Professor of Medicine, Microbiology and Immunology Dartmouth Hitchcock Medical Center Lebanon, NH Christopher T. Ritchlin, MD Associate Professor of Medicine Allergy, Immunology and Rheumatology Unit University of Rochester Medical Center Rochester, NY Gregg J. Silverman, MD* Professor of Medicine Director, Laboratory of B-Cell Immunology Division of Rheumatology, Allergy, and Immunology University of California San Diego School of Medicine La Jolla, CA

* Planning Committee for Advances in B Cell Biology: RA, SLE, and Vasculitis

Back to Top

 

Agenda

OCTOBER 22-23, 2010 Westin Times Square New York, New York For full New York Agenda please click here
RHEUMATOLOGY HIGHLIGHTS REPORT LIVE

Presentations will include: New Issues in Biologics (includes TNF Inhibitors, B Cells, New Molecules) Spondyloarthropathy, Psoriatic Arthritis New Issues in the Safety of Biologics Rheumatoid Arthritis: Clinical Aspects of Nonbiologic DMARDS in RA Interactive Faculty Roundtable Case Discussions Advances in Gout and Other Crystal Diseases Vasculitis: Pathology, Diagnosis, and Treatment SLE and Miscellaneous Rheumatic Disorders Interactive Faculty Roundtable Case Discussions

ADVANCES IN B CELL BIOLOGY: RA, SLE, AND VASCULITIS

Presentations will include: New and Emerging B-Cell Therapies Advances in B-Cell Therapy for RA Evolving Patterns of Serious and Opportunistic Infections in Biologic Therapies Advances in B-Cell–Directed Therapies in SLE and Other Autoimmune Diseases Emerging Role of B-Cell–Directed Therapies for Vasculitis Advances in B-Cell Science, Interactive Case Discussion

Back to Top

 

Locations

	NEW YORK, NEW YORK October 22-23, 2010 Westin Times Square New York, New York
	Hotel Accommodations A block of rooms has been reserved at the Westin Times Square until September 29, 2010. To make your reservation, click www.ccfcme.org/RHR10Hotel for a special rate of $349 single/double plus tax.
	Parking Valet parking is available at the hotel for a daily charge of $55.  Other lots are nearby, but are not affiliated with the hotel.
	NEW YORK Hotel Google Map Location
	View Larger Map

Back to Top

 

Additional Information

For further information about this symposium, contact Cleveland Clinic Center for Continuing Education at:

Local: 216-448-0770
Toll Free: 800-238-6750

For questions about registering, email CMEregistration@ccf.org or call 216-448-0777.

Back to Top

 

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

Back to Top

 

Americans with Disabilities Act

The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify the Center for Continuing Education at 216-448-0770 at least 2 weeks prior to the activity.

Back to Top

 

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates these educational activities for a maximum of 9.0 AMA PRA Category 1 Credits^TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Rheumatology Highlights Report: Maximum 5.5 AMA PRA Category 1 Credits^TM.
Advances in B Cell Biology: RA, SLE, and Vasculitis: Maximum 3.5 AMA PRA Category 1 Credits^TM.

Participants claiming CME credit from these activities may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit

Back to Top

 

Registration and Cancellation

Preregistrations are accepted online for the New York symposium until 11 am ET, October 19, 2010. To register after this date, you must do so onsite.

In case of cancellation, a full refund will be made if canceled by October 1, 2010. After October 1, 2010, a $50 cancellation fee will be deducted from your refund. Written notification of your cancellation is required in order to process your refund.

No refunds for the New York symposium will be issued after November 23, 2010.

 

Online Registration/Fees

Registration fee includes continental breakfasts, refreshment breaks, lunch, and syllabus for each course.

Category	Either Location
All Attendees to Rheumatology Highlights Report Live	$100.00
Register for the NEW YORK (OCT. 22-23, 2010) Rheumatology Highlights Report Live & Advances in B Cell Biology: : RA, SLE, and Vasculitis

Back to Top